CCK 4 -induced panic in healthy subjects I: psychological and cardiovascular effects

By Jerabek I.   Boulenger J.-P.   Bradwejn J.   Lavallee Y.-J.   B. Jolicoeur F.  

European Neuropsychopharmacology, Vol. 9, Iss. 1, 1999-01 ,pp. : 149-155

Elsevier

Access to resources Recommend Favorite

Peripheral monoamines and CCK 4 -induced panic attacks in healthy subjects

By Jerabek I.   Boulenger J.P.   Jolicoeur F.B.   Bradwejn J.   Drumheller A.   Lavalleacute e Y.J.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 364-364

Elsevier

Access to resources Recommend Favorite

The panic-inducing properties of the cholecystokinin tetrapeptide CCK 4 in patients with panic disorder

By van Megen H.J.G.M.   Westenberg H.G.M.   Den Boer J.A.   Kahn R.S.  

European Neuropsychopharmacology, Vol. 6, Iss. 3, 1996-08 ,pp. : 187-194

Elsevier

Access to resources Recommend Favorite

Independent Component Analysis Applied to Pharmacological Magnetic Resonance Imaging (phMRI): New Insights Into the Functional Networks Underlying Panic Attacks as Induced by CCK-4

By  

Current Pharmaceutical Design, Vol. 14, Iss. 33, 2008-11 ,pp. : 3492-3507

Bentham Science Publishers

Access to resources Recommend Favorite

Would CCK-4 challenges be useful to predict anti-anxiety effects of non anti-panic drugs?

By Boulenger J.P.   Jerabek I.   Cocirc teacute G.   Lavalleacute e Y.J.   Jolicoeur F.B.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 374-375

Elsevier

Access to resources Recommend Favorite